aTYR PHARMA INC Annual Operating Income (Loss) in USD from 2013 to 2023

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: aTYR PHARMA INC quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2023.
aTYR PHARMA INC Operating Income (Loss) for the quarter ending September 30, 2024 was -$18.1M, a 43.8% decline year-over-year.
aTYR PHARMA INC Operating Income (Loss) for the twelve months ending September 30, 2024 was -$68.1M, a 45.1% decline year-over-year.
aTYR PHARMA INC annual Operating Income (Loss) for 2023 was -$54.9M, a 18.4% decline from 2022.
aTYR PHARMA INC annual Operating Income (Loss) for 2022 was -$46.4M, a 36.4% decline from 2021.
aTYR PHARMA INC annual Operating Income (Loss) for 2021 was -$34M, a 114% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Annual (USD)

Operating Income (Loss), YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2023	-$54.9M	-$8.52M	-18.4%	Jan 1, 2023	Dec 31, 2023	10-K	2024-03-14
2022	-$46.4M	-$12.4M	-36.4%	Jan 1, 2022	Dec 31, 2022	10-K	2024-03-14
2021	-$34M	-$18.1M	-114%	Jan 1, 2021	Dec 31, 2021	10-K	2024-03-14
2020	-$15.9M	+$7.07M	+30.8%	Jan 1, 2020	Dec 31, 2020	10-K	2023-03-14
2019	-$23M	+$9.84M	+30%	Jan 1, 2019	Dec 31, 2019	10-K	2022-03-15
2018	-$32.8M	+$14.3M	+30.4%	Jan 1, 2018	Dec 31, 2018	10-K	2021-03-24
2017	-$47.1M	+$10.8M	+18.6%	Jan 1, 2017	Dec 31, 2017	10-K	2020-03-26
2016	-$57.9M	-$10.3M	-21.7%	Jan 1, 2016	Dec 31, 2016	10-K	2019-03-26
2015	-$47.6M	-$24.1M	-102%	Jan 1, 2015	Dec 31, 2015	10-K	2018-03-20
2014	-$23.6M	-$4.01M	-20.5%	Jan 1, 2014	Dec 31, 2014	10-K	2017-03-16
2013	-$19.5M			Jan 1, 2013	Dec 31, 2013	10-K	2016-03-30

Showing 1 to 11 of 11 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.